Healthcare - Biotechnology - NASDAQ - US
$ 5.08
-8.96 %
$ 750 M
Market Cap
-3.79
P/E
Price Target
Average
101.77%
Revenue Forecast
Estimate
23.68%
EBIT
Estimate
--6.27%
Net Income
Estimate
32.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Adaptive Biotechnologies Corporation
Wall Street analysts predict an average 1-year price target for ADPT of $10.2 , with forecasts ranging from a low of $5 to a high of $18 .
ADPT Lowest Price Target
Wall Street Target
5 USD
-1.57%
ADPT Average Price Target
Wall Street Target
10.2 USD
101.77%
ADPT Highest Price Target
Wall Street Target
18 USD
254.33%
REVENUE FORECAST
Revenue Forecast Chart ADPT
EBIT FORECAST
EBIT Forecast Chart ADPT
NET INCOME FORECAST
Net Income Chart ADPT